United Therapeutics Board Authorizes Additional $2 Billion Share Buyback

PUBT · 3d ago
United Therapeutics Board Authorizes Additional $2 Billion Share Buyback
  • United Therapeutics' board authorized an additional $2 billion common stock repurchase program, available through October 21, 2027.
  • An accelerated share repurchase transaction entered into in September 2026 is scheduled to end in the fourth quarter of 2026.
  • The existing transaction will not reduce the new authorization, which carries no minimum purchase requirement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20261022071884) on October 22, 2026, and is solely responsible for the information contained therein.